Section: Partnerships and Cooperations

National Initiatives

• Plan Cancer NUMEP: 2016–2019. Numerics for Clinical Electroporation

• Funding: 460 kE.

• Partners: Institut de Pharmacologie de Toulouse, CHU J. Verdier de Bondy.

• Duration: Octobre 2016—Septembre 2019.

• Project leader: C. Poignard

• Co-PI: M-P. Rols (IPBS), O. Séror (CHU J. Verdier)

• Project acronym - Moglimaging: Modeling of Glioblastoma treatment-induced resistance and heterogeneity by multi-modal imaging.

• Partners - Inria Monc, IUCT, Institut Pasteur, Univ. Grenoble, INSERM, Inria Mamba.

• Duration - from Nov. 2016 to May 2020.

• Coordinator - E. Cohen-Jonathan Moyal, Institut Universitaire du Cancer Toulouse / Local coordinator - O. Saut.

• Team participants - S. Benzekry, A. Collin, C. Poignard, O. Saut.

• Title: Plan Cancer Systems Biology of Renal Carcinoma using a Mouse RCC model

• Partners : LAMC, INSERM-Univ. Bordeaux.

• Duration - June 2018 to June 2021

• Team participants: O. Saut, S. Benzekry (co-PI)

• Funding: 116.64k€

• Plan Cancer QUANTIC: 2020–2022. QUANTitative modeling combined to statistical learning to understand and predict resistance to Immune-checkpoint inhibition in non-small cell lung Cancer.

• Funding: 338 k€

• Partners: Inria Team MONC, SMARTc (Centre de Recherche sur le Cancer de Marseille, Inserm, CNRS), Assistance Publique Hôpitaux de Marseille

• Duration: Décembre 2019 — Décembre 2022

• Project leader: S. Benzekry

• Co-PI: D. Barbolosi (SMARTc), F. Barlési (AP-HM)

• Title: Minimally and non-invasive methods for early detection and/or progression of low grade glioma

• Partners: Inria Monc, Inria SISTM, INSERM, Humanitas Research Hostital, Univ. Bergen

• Acronym: Glioma PRD

• Team participants: A. Collin, C. Poignard, O. Saut (local PI)

• Total funds: 1M150, Monc's share 275k€.

Labex TRAIL (http://trail.labex.u-bordeaux.fr): MOD Project Consolidation. 1 2-years post-doc position (100k€), led by A. Collin, 1 PhD funding (100k€) led by O. Saut.